Academic
Publications
Beta3 Adrenoceptor Agonists as Antidiabetic and Anti-obesity Drugs in Humans

Beta3 Adrenoceptor Agonists as Antidiabetic and Anti-obesity Drugs in Humans,10.2174/1381612013397339,Current Pharmaceutical Design,C. J. de Souza,B.

Beta3 Adrenoceptor Agonists as Antidiabetic and Anti-obesity Drugs in Humans   (Citations: 8)
BibTex | RIS | RefWorks Download
Journal: Current Pharmaceutical Design - CURR PHARM DESIGN , vol. 7, no. 14, pp. 1433-1449, 2001
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...Expression of fl3 adrenoceptors in human tissues is now well documented: these receptors are primarily expressed in adipose tissue, where they regulate fat metabolism and thermogenesis, suggesting a possible use of fl3-adrenoceptor selective agonists as antidiabetic and antiobesity drugs (3, 4). fl3-Adrenoceptor mRNA distribution studies have also localized the receptor in the human and in the rat gastric fundus and small intestine, ...

    Maristella Adamiet al. Pharmacological Evidence for β3 Adrenoceptors in the Control of Rat Ga...

Sort by: